Oxford Bioscience Partners

Oxford Bioscience Partners is an early-stage venture capital investment firm that invests in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. It was established in 1992 by Cornelius T. Ryan and Edmund M. Olivier.

Oxford Biosciences Partners has approximately $1B of committed capital under management. It has invested in over 140 life science companies worldwide, including Yolia Health, CardioFocus, Affinium Pharmaceuticals, Mitralign, and Seahorse Bioscience.